Neurology and Neurosurgery - Global Neurology Academy

Episodes 193-208 of 365

Unmet Needs in Rehabilitation Research for Multiple Sclerosis
Unmet Needs in Rehabilitation Research for Multiple Sclerosis
NeuroFrontiers
Unmet Needs in Rehabilitation Research for Multiple Sclerosis
- Robert Motl, PhD
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
Heart Matters
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
Telehealth in MS Care: Addressing the Potential for Improvement and Concerns
Telehealth in MS Care: Addressing the Potential for Improvement and Concerns
NeuroFrontiers
Telehealth in MS Care: Addressing the Potential for Improvement and Concerns
- Marisa McGinley, DO
MS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
MS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
NeuroFrontiers
MS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
- Yinan Zhang, MD
Addressing Healthcare Barriers in Patients with Multiple Sclerosis
Addressing Healthcare Barriers in Patients with Multiple Sclerosis
NeuroFrontiers
Addressing Healthcare Barriers in Patients with Multiple Sclerosis
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
NeuroFrontiers
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
- Andrew Wilner, MD, FACP, FAAN
- Marcus E. Peter, PhD
Schizophrenia Diagnosis: The Importance of a Collaborative Approach
Schizophrenia Diagnosis: The Importance of a Collaborative Approach
NeuroFrontiers
Schizophrenia Diagnosis: The Importance of a Collaborative Approach
- Ashley Baker, MSN, PMHNP
- Morris Goldman, MD
- Dara Sanandaji
A Successful and Safe Stem Cell Therapy for Progressive MS
A Successful and Safe Stem Cell Therapy for Progressive MS
NeuroFrontiers
A Successful and Safe Stem Cell Therapy for Progressive MS
- Charles Turck, PharmD, BCPS, BCCCP
- Stefano Pluchino, MD, PhD
Examining the Role of Toxic Tau Proteins in Alzheimer's Disease
Examining the Role of Toxic Tau Proteins in Alzheimer's Disease
NeuroFrontiers
Examining the Role of Toxic Tau Proteins in Alzheimer's Disease
- Andrew Wilner, MD, FACP, FAAN
- George Bloom, PhD
New Study Shows EBV-Specific T-Cells Contribute to MS Development
New Study Shows EBV-Specific T-Cells Contribute to MS Development
NeuroFrontiers
New Study Shows EBV-Specific T-Cells Contribute to MS Development
- J. William Lindsey
Alzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound
Alzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound
NeuroFrontiers
Alzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound
- Andrew Wilner, MD, FACP, FAAN
- Marc Haut, PhD
First Episode Psychosis: Improving Patient Outcomes Through Early Intervention
First Episode Psychosis: Improving Patient Outcomes Through Early Intervention
NeuroFrontiers
First Episode Psychosis: Improving Patient Outcomes Through Early Intervention
- Ashley Baker, MSN, PMHNP
- Hannah Brown, MD
Investigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test
Investigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test
NeuroFrontiers
Investigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test
- Andrew Wilner, MD, FACP, FAAN
- William A. Kilgo, MD
Adverse Childhood and Lifespan Stressors Take a Toll on MS Disease Severity
Adverse Childhood and Lifespan Stressors Take a Toll on MS Disease Severity
NeuroFrontiers
Adverse Childhood and Lifespan Stressors Take a Toll on MS Disease Severity
- Andrew Wilner, MD, FACP, FAAN
- Carri Polick, PhD, RN
MS in Black and Hispanic Patients: Examining Prevalence and Disease Characteristics
MS in Black and Hispanic Patients: Examining Prevalence and Disease Characteristics
NeuroFrontiers
MS in Black and Hispanic Patients: Examining Prevalence and Disease Characteristics
- Jennifer Caudle, DO
- Mitzi Joi Williams, MD
Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS
Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS
NeuroFrontiers
Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS
- Charles Turck, PharmD, BCPS, BCCCP
- Anibal Chertcoff, MD

13/11